The use of interventional radiology in the diagnosis and treatment of gastric bleeding in Burkitt lymphoma Opis przypadku

##plugins.themes.bootstrap3.article.sidebar##

PDF (English)


Opublikowane: paź 31, 2023
DOI: https://doi.org/10.24292/01.OR.133301023
Słowa kluczowe:
Burkitt lymphoma, bleeding, interventional radiology

##plugins.themes.bootstrap3.article.main##

Grzegorz Kade
Clinical Hospital of the Ministry of Internal Affairs and Administration with the Warmia-Mazury Oncology Centre, Olsztyn
Adam Kade
Student of the Faculty of Medicine, Medical University of Lodz
Agata Kurowska
Student of the Faculty of Medicine, Medical University of Lodz
Rafał Kidziński
Diagnostic Imaging Department, Clinical Hospital of the Ministry of Internal Affairs and Administration with the Warmia-Mazury Oncology Centre, Olsztyn
Krzysztof Pyra
Department of Interventional Radiology and Neuroradiology, Medical University of Lublin
Sebastian Spaleniak
Department of Internal Medicine and Nephrodiabetology, Medical University of Lodz
Janusz Hałka
Department of Clinical Hematology, Clinical Hospital of the Ministry of Internal Affairs and Administration with the Warmia-Mazury Oncology Centre, Olsztyn

Abstrakt

The paper presents a case of Burkitt lymphoma manifested by bleeding from a gastric ulcer. The control of bleeding required the use of diagnostic and therapeutic methods of interventional radiology.

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

##plugins.themes.bootstrap3.article.details##

Jak cytować
1.
Kade G, Kade A, Kurowska A, Kidziński R, Pyra K, Spaleniak S, Hałka J. The use of interventional radiology in the diagnosis and treatment of gastric bleeding in Burkitt lymphoma. OncoReview [Internet]. 31 październik 2023 [cytowane 10 czerwiec 2026];13(3(51):85-9. Dostępne na: https://www.journalsmededu.pl/index.php/OncoReview/article/view/2908
Numer
Tom 13 Nr 3(51) (2023)
Dział
PERSONALIZED ONCOLOGY

Copyright: ? Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

Bibliografia

1. Swerdlow SH, Campo E, Pileri SA et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 19: 127(20): 2375-90. http://doi.org/10.1182/blood-2016-01-643569.
2. Harne PS, Macklin J, Muniraj T. Disseminated Burkitt lymphoma presenting as massive gastrointestinal bleed. Proc (Bayl Univ Med Cent). 2020; 33(3): 433-5. http://doi.org/10.1080/08998280.2020.1747835.
3. Caetano Dos Santos FL, Michalek IM, Wojciechowska U et al. Improved survival of Burkitt lymphoma/leukemia patients: observations from Poland, 1999-2020. Ann Hematol. 2022; 101(5): 1059-65. http://doi.org/10.1007/s00277-022-04758-2.
4. Thomas DA, Faderl S, O'Brien S et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006; 106(7): 1569-80. http://doi.org/10.1002/cncr.21776.
5. Roschewski M, Staudt LM, Wilson WH. Burkitt's Lymphoma. N Engl J Med. 2022; 387(12): 1111-22. http://doi.org/10.1056/NEJMra2025746.
6. Crombie J, LaCasce A. The treatment of Burkitt lymphoma in adults. Blood. 2021; 137(6): 743-50. http://doi.org/10.1182/blood.2019004099.